Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-01-14
2008-08-12
Lukton, David (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S018700, C514S411000, C530S331000
Reexamination Certificate
active
07410951
ABSTRACT:
Derivatives of hemiasterlin or Geodiamolide G having anti-mitotic activities and useful in treating cancer. These derivatives are represented by formula Iwherein Y, n, R1, R2, R3, R7, R70, R71, R72, R74, and R75are as defined in the specification.
REFERENCES:
patent: 4285935 (1981-08-01), Etschenberg et al.
patent: 4371536 (1983-02-01), Braestrup et al.
patent: 5081225 (1992-01-01), O'Sullivan et al.
patent: 5340802 (1994-08-01), Shiosaki et al.
patent: 5356794 (1994-10-01), Fromageot et al.
patent: 5661175 (1997-08-01), Kashman et al.
patent: 5721250 (1998-02-01), Morriello et al.
patent: 5736517 (1998-04-01), Bogden et al.
patent: 7064211 (2006-06-01), Kowalczyk et al.
patent: 216551 (1989-09-01), None
patent: 224706 (1990-07-01), None
patent: 93/17701 (2006-09-01), None
Lippke K.P., (Archiv der Pharmazie 320(2), 145-153, 1987).
Shintaro, Inoue (Analytical Biochemistry 132(2) 468-80, 1983).
Baeza, Claudio Rivera (Acta Chemica Scandinavica 48(5), 434-8, 1994).
Chan et al., “Stereostructures of Geodiamolides A and B, Novel Cyclodepsipeptides from the Marine SpongeGeodiasp.,” J. Org. Chem., 1987, vol. 52, No. 14, pp. 3091-3093.
Coleman et al., “Cytotoxic Peptides from the Marine SpongeCymbastelasp.,” Tetrahedron, 1995, vol. 51, No. 39, pp. 10653-10662.
Coleman et al., “Hemiasterlin Methyl Ester,” Acta Cryst., 1996, C52, pp. 1525-1527.
Crews et al., “Milnamide A, an Unusual Cytotoxic Tripeptide from the Marine SpongeAuletta cf. constricta,” J. Org. Chem., 1994, vol. 59, No. 11, pp. 2932-2934.
Fabian et al., “Growth Modulation and Differentiation of Acute Myeloid Leukemia Cells by Jaspamide,” Experimental Hematology, 1995, vol. 23, No. 7, pp. 583-587.
Huang et al., “Main Chain and Side Chain Chiral Methylated Somatostatin Analogs: Syntheses and Conformational Analyses,” J. Am. Chem. Soc., 1992, vol. 114, No. 24, pp. 9390-9401.
Minaev et al., “Fluorescence Study of A-128-OP Antibiotic,” Viniti Deposited Publication, 1977, 2778-77, pp. 1-14.
Minaev et al., “Fluorescence Study of A-128-OP Antibiotic,” Chemical Abstracts, 1979, vol. 91, p. 710.
Talpir et al., “Hemiasterlin and Geodiamolide TA; Two New Cytotoxic Peptides from the Marine Sponge Hemiasterella Minor (Kirkpatrick),” Tetrahedron Letters, 1994, vol. 35, No. 25, pp. 4453-4456.
Hungarian Search Report for corresponding Hungarian Application No. P0105460 in English, Jul. 2002.
Hungarian Abstract of document cited in Hungarian Search Report (C9)—HU P9900728 A, Aug. 1999.
Allen Theresa
Andersen Raymond
Coleman John
De Silva Dilip
Kong Fangming
Arent & Fox LLP
Lukton David
The University of British Columbia
LandOfFree
Biologically active peptides and compositions, their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biologically active peptides and compositions, their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically active peptides and compositions, their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3999786